Worthing Hospital is a medium-sized District General Hospital located in Worthing, West Sussex, England. It is managed by University Hospitals Sussex NHS Foundation Trust.

During the past decade, Worthing Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Worthing Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 6 trials, followed by "University of Leeds" with 3 trials sponsored, "University College, London" with 2 trials sponsored, "Astute Medical, Inc." with 1 trials sponsored and "Cancer Research UK" with 1 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Worthing Hospital" #1 collaborator was "Cancer Research UK" with 6 trials as a collaborator, "Medical Research Council" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "Takeda" with 2 trials as a collaborator and "Borstkanker Onderzoek Groep" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Worthing Hospital" are "Prostate Cancer" (6 trials), "Breast Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Bladder Cancer" (2 trials) and "Leukemia" (2 trials). Many other conditions were trialed in "Worthing Hospital" in a lesser frequency.

Most popular intervention types in "Worthing Hospital" are "Drug" (27 trials), "Biological" (7 trials), "Other" (6 trials), "Radiation" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (3 trials), "fludarabine phosphate" (3 trials), "fluorouracil" (3 trials), "Prednisolone" (2 trials) and "carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Worthing Hospital" are 24 trials for "All" genders, 7 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Worthing Hospital". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Worthing Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Worthing Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".